Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 701 (USA) (Dr. Reyes)
· consented 2013-05-30
Adverse events
6
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Mild APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-16 (study day 48.0); relationship: PROBABLE
mild
assessed
2026-08-18
Mild BACK PAIN — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-13 (study day 137.0); relationship: NONE
mild
assessed
2026-08-18
Mild BACK PAIN — outcome: RECOVERED/RESOLVED; onset 2013-10-13 (study day 137.0); relationship: NONE
moderate
assessed
2026-08-18
Moderate HEADACHE — outcome: NOT RECOVERED/NOT RESOLVED; onset 1986; relationship: POSSIBLE
mild
assessed
2026-08-18
Mild HEADACHE — outcome: NOT RECOVERED/NOT RESOLVED; onset 1986; relationship: POSSIBLE
mild
assessed
2026-08-18
Mild NAUSEA — outcome: RECOVERED/RESOLVED; onset 2013-06-14 (study day 16.0); relationship: REMOTE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.